Evidence map›Paper›PMID 37377481›Full record

ArticleCanadian journal of kidney health and disease2023

Development and Validation of a Predictive Risk Algorithm for Bleeding in Individuals on Long-term Hemodialysis: An International Prospective Cohort Study (BLEED-HD).

Mohit Madken, Ranjeeta Mallick, Emily Rhodes, Roshanak Mahdavi, Anan Bader Eddeen, Gregory L Hundemer, Dearbhla M Kelly, Angelo Karaboyas, Bruce Robinson, Brian Bieber and 5 more

Open access · goldAbstract read
In one paragraph

Article in Canadian journal of kidney health and disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Treatment strategies of the thromboembolic risk in kidney failure patients with atrial fibrillation.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 4 countries.

Mohit MadkenDepartment of Medicine, The Ottawa Hospital, ON, Canada.ORCID https://orcid.org/0000-0002-2975-0142
Ranjeeta MallickThe Ottawa Methods Centre, The Ottawa Hospital, ON, Canada.
Emily RhodesOttawa Hospital Research Institute, The Ottawa Hospital, ON, Canada.
Roshanak MahdaviICES, Toronto, ON, Canada.
Anan Bader EddeenICES, Toronto, ON, Canada.
Gregory L HundemerDepartment of Medicine, The Ottawa Hospital, ON, Canada.ORCID https://orcid.org/0000-0003-3559-3531
Dearbhla M KellyDepartment of Nephrology, St. James Hospital, Dublin, Ireland.
Angelo KaraboyasArbor Research Collaborative for Health, Ann Arbor, MI, USA.
Bruce RobinsonDepartment of Internal Medicine, University of Michigan, Ann Arbor, USA.
Brian BieberArbor Research Collaborative for Health, Ann Arbor, MI, USA.
Amber O MolnarICES, Toronto, ON, Canada.ORCID https://orcid.org/0000-0003-4549-0202
Sunil V BadveDepartment of Renal Medicine, St. George Hospital, Sydney, NSW, Australia.
Peter TanuseputroICES, Toronto, ON, Canada.
Gregory KnollDepartment of Medicine, The Ottawa Hospital, ON, Canada.
Manish M SoodDepartment of Medicine, The Ottawa Hospital, ON, Canada.ORCID https://orcid.org/0000-0002-9146-2344
Ottawa Hospital · CAArbor Research Collaborative for Health · USMcMaster University · CAThe George Institute for Global Health · AUTrinity College Dublin · IEUniversity of Michigan · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Individuals with kidney disease are at a high risk of bleeding and as such tools that identify those at highest risk may aid mitigation strategies. Objective: We set out to develop and validate a prediction equation (BLEED-HD) to identify patients on maintenance hemodialysis at high risk of bleeding. Design: International prospective cohort study (development); retrospective cohort study (validation). Settings: Development: 15 countries (Dialysis Outcomes and Practice Patterns Study [DOPPS] phase 2-6 from 2002 to 2018); Validation: Ontario, Canada. Patients: Development: 53 147 patients; Validation: 19 318 patients. Measurements: Hospitalization for a bleeding event. Methods: Cox proportional hazards models. Results: Among the DOPPS cohort (mean age, 63.7 years; female, 39.7%), a bleeding event occurred in 2773 patients (5.2%, event rate 32 per 1000 person-years), with a median follow-up of 1.6 (interquartile range [IQR], 0.9-2.1) years. BLEED-HD included 6 variables: age, sex, country, previous gastrointestinal bleeding, prosthetic heart valve, and vitamin K antagonist use. The observed 3-year probability of bleeding by deciles of risk ranged from 2.2% to 10.8%. Model discrimination was low to moderate (c-statistic = 0.65) with excellent calibration (Brier score range = 0.036-0.095). Discrimination and calibration of BLEED-HD were similar in an external validation of 19 318 patients from Ontario, Canada. Compared to existing bleeding scores, BLEED-HD demonstrated better discrimination and calibration (c-statistic: HEMORRHAGE = 0.59, HAS-BLED = 0.59, and ATRIA = 0.57, c-stat difference, net reclassification index [NRI], and integrated discrimination index [IDI] all Limitations: Dialysis procedure anticoagulation was not available; validation cohort was considerably older than the development cohort. Conclusion: In patients on maintenance hemodialysis, BLEED-HD is a simple risk equation that may be more applicable than existing risk tools in predicting the risk of bleeding in this high-risk population.

Indexed as

bleedingDOPPShemodialysisinternationalrisk prediction models

Identifiers

PMID37377481
PMCPMC10291537
OpenAlexW4381996806

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.